14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ANVS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Annovis Bio, Inc. stock price ended at $5.35 on Tuesday, after losing 0.742%.
(Updated on May 07, 2024)

Sell candidate since Apr 29, 2024 Loss -26.51% PDF

The Annovis Bio, Inc. stock price fell by -0.742% on the last day (Tuesday, 7th May 2024) from $5.39 to $5.35. During the last trading day the stock fluctuated 6.92% from a day low at $5.20 to a day high of $5.56. The price has been going up and down for this period, and there has been a -54.97% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -63 thousand shares and in total, 328 thousand shares were bought and sold for approximately $1.76 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $5.16 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -3.77% during the next 3 months and, with a 90% probability hold a price between $4.96 and $17.25 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ANVS Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, May 03, 2024, and so far it has risen 3.28%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Annovis Bio, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $5.76 and $10.40. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Annovis Bio, Inc. stock

Annovis Bio, Inc. finds support from accumulated volume at $5.18 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.360 between high and low, or 6.92%. For the last week, the stock has had daily average volatility of 12.77%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ANVS) For The Upcoming Trading Day Of Wednesday 8th

For the upcoming trading day on Wednesday, 8th we expect Annovis Bio, Inc. to open at $5.37, and during the day (based on 14 day Average True Range), to move between $3.60 and $7.10, which gives a possible trading interval of +/-$1.75 (+/-32.65%) up or down from last closing price. If Annovis Bio, Inc. takes out the full calculated possible swing range there will be an estimated 65.30% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $5.45 (1.87%) than the support at $5.18 (3.18%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Earnings coming up

Annovis Bio, Inc. will release earnings BMO on Thursday, May 09, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.87. We will update the financials statements for Annovis Bio, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 9.36% in the first trading day after earnings release.

Is Annovis Bio, Inc. stock A Buy?

Annovis Bio, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.633 Sell Candidate Unchanged

Predicted Opening Price for Annovis Bio, Inc. of Wednesday, May 8, 2024

Fair opening price May 8, 2024 Current price
$5.37 ( 0.374%) $5.35

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ANVS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.73 7.10 %
R2 5.59 4.53 %
R1 5.51 2.94 %
Current price: 5.35
Support S1 5.23 -2.20 %
S2 5.15 -3.78 %
S3 5.01 -6.36 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 6.11 14.21 %
R2 5.57 4.11 %
R1 5.45 1.87 %
Current price 5.35
Support S1 5.18 -3.18%
S2 0 .
S3 0 .

FAQ

What is the symbol for Annovis Bio, Inc. Stock and on which exchange is it traded?
The symbol for Annovis Bio, Inc. is ANVS and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Annovis Bio, Inc. Stock?
Annovis Bio, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Annovis Bio, Inc. Stock?
Annovis Bio, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Annovis Bio, Inc. Stock.

What's the current price of Annovis Bio, Inc. Stock?
As of the end of day on the May 07, 2024, the price of an Annovis Bio, Inc. (ANVS) share was $5.35.

What is the 52-week high and low for Annovis Bio, Inc. Stock?
The 52-week high for Annovis Bio, Inc. Stock is $22.49 and the 52-week low is $4.86.

What is the market capitalization of Annovis Bio, Inc. Stock?
As of the May 07, 2024, the market capitalization of Annovis Bio, Inc. is 59.351M.

When is the next earnings date for Annovis Bio, Inc.?
The upcoming earnings date for Annovis Bio, Inc. is May 09, 2024.
Click to get the best stock tips daily for free!

About Annovis Bio, Inc.

Annovis Bio. Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease in Down Syndrome and other chronic neurodegenerative disorders. It is also developing ANVS405 for prote... ANVS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT